Safely Prescribing Controlled Substances in Oncology
-
Register
- Non-member - $75
- Member - Free!
The Safely Prescribing Controlled Substances in Oncology modules by APSHO include 13 comprehensive, and self-paced modules, thoughtfully crafted to equip you with the knowledge and expertise necessary to safely prescribe controlled substances and to understand and manage substance use disorders in the hematology/oncology setting. (These modules will meet the DEA requirement for 8 hours of training on substance use disorder.) 9 CE-Accredited Hours (3.5 pharmacology hours for ANCC accreditation)
-
Contains 5 Component(s), Includes Credits
0.50 CE-Accredited Hours (0.25 pharmacology hours for ANCC accreditation)
- Define SUD based on accepted DSM-5 definition
- Articulate the impact of SUD on cancer outcomes
- Recognize the physical and psychosocial signs of SUD
Antonia Corrigan
MSN, ANP-C, ACHPN
Atrium Health Levine Cancer Institute
Antonia Corrigan has no relevant financial relationships to disclose.
-
Contains 5 Component(s), Includes Credits
0.50 CE-Accredited Hours (0.25 pharmacology hours for ANCC accreditation)
- Define Substance Use Disorder (SUD)
- Recognize the importance of screening for SUD
- Review the most frequently used screening tools
Antonia Corrigan
MSN, ANP-C, ACHPN
Atrium Health Levine Cancer Institute
Antonia Corrigan has no relevant financial relationships to disclose.
-
Contains 5 Component(s), Includes Credits
0.75 CE-Accredited Hours (0.75 pharmacology hours for ANCC accreditation)
- Define risk/benefit ratio in opioid prescribing
- Discuss the spectrum of opioid use disorders
- Describe a plan of care to manage patients who exhibit signs of misuse, abuse, or diversion including the Compassion High Alert Team (CHAT) model and deprescribing practices
Jeannine M. Brant
PhD, APRN, AOCN, FAAN
City of Hope
Jeannine Brant has no relevant financial relationships to disclose.
-
Contains 5 Component(s), Includes Credits
1.00 CE-Accredited Hours (0.50 pharmacology hours for ANCC accreditation)
- Understand the impact of the opioid epidemic on prescribing controlled substances
- Describe the classification of controlled substances
- Define the educational needs and safe prescribing practices for controlled substances
Vanessa Sanne
RN, FNP-C, ACHPN
Compass Oncology
Vanessa Sanne has no relevant financial relationships to disclose.
-
Contains 5 Component(s), Includes Credits
0.75 CE-Accredited Hours (0.50 pharmacology hours for ANCC accreditation)
- Define the ethical and legal issues regarding patients with substance use disorders in oncology care
- Describe the REMS process for prescribing select opioids
- Illustrate legal and ethical implications for APs using a case-based approach
Jeannine M. Brant
PhD, APRN, AOCN, FAAN
City of Hope
Jeannine Brant has no relevant financial relationships to disclose.
-
Contains 5 Component(s), Includes Credits
0.50 CE-Accredited Hours (0.25 pharmacology hours for ANCC accreditation)
- Recognize risk factors for substance use disorder and articulate examples
- Describe the impact family history has as a risk factor for substance use disorders
- Relate the concept of resilience as a protective measure against substance use disorder
Gretchen A. McNally
PhD, ANP-BC
Arthur G. James Cancer Hospital, The Ohio State University
Gretchen A. McNally has no relevant financial relationships to disclose. -
Contains 5 Component(s), Includes Credits
0.75 CE-Accredited Hours (0.00 pharmacology hours for ANCC accreditation)
- Define stigma and understand the history of stigma in substance use disorders (SUDs)
- Understand contributing factors and the consequences of stigma in SUDs and how it relates to health outcomes with people with SUDs
- Develop strategies for mitigating stigma in our communities and healthcare settings
Vanessa Sanne
RN, FNP-C, ACHPN
Compass Oncology
Vanessa Sanne has no relevant financial relationships to disclose.
-
Contains 5 Component(s), Includes Credits
0.75 CE-Accredited Hours (0.00 pharmacology hours for ANCC accreditation)
- Describe the frequency of trauma and the subsequent impact of trauma on patients’ health outcomes.
- List the six key principles of organizational trauma-informed care as identified by Substance Abuse and Mental Health Administration (SAMHSA).
- Name and briefly describe screening tools use to guide the practitioner in the need for referrals.
Sharon Moore, D.Ph.
Academic Detailer
ONE Tennessee and Metro Drug Coalition
Sharon Moore has no relevant financial relationships to disclose.
-
Contains 5 Component(s), Includes Credits
0.50 CE-Accredited Hours (0.00 pharmacology hours for ANCC accreditation)
- Describe elements of effective communication
- Identify barriers to effective communication
- Develop strategies to improve communication
Katie Parker
FNP-BC, ACHPN
West Cancer Center
Katie Parker has no relevant financial relationships to disclose.
-
Contains 5 Component(s), Includes Credits
1.00 CE-Accredited Hours (0.25 pharmacology hours for ANCC accreditation)
- Discuss substance use disorder stigma and how this can affect patient/caregiver education
- Describe key elements of patient assessment may guide the patient/caregiver educational plan
- List fundamental elements that should be included in the patient/caregiver educational plan
Claudia Anderson
APRN, ACNP, ACHPN
Mayo Clinic
Claudia Anderson has no relevant financial relationships to disclose.
